We are live on ! Find out more
VVA

Vida Ventures Advisors Portfolio holdings

AUM $29.4M
1-Year Est. Return 93.58%
This Fund
S&P 500
This Quarter Est. Return
+48.64%
1 Year Est. Return
+93.58%
3 Year Est. Return
+153.74%
5 Year Est. Return
+14.63%
10 Year Est. Return
AUM
$15.9M
AUM Growth
+$2.28M
Cap. Flow
-$2.28M
Cap. Flow %
-14.33%
Top 10 Hldgs %
100%
Holding
3
New
Increased
Reduced
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
KRON
Kronos Bio
KRON
+$2.28M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KYTX icon
1
Kyverna Therapeutics
KYTX
$481M
$13.9M 87.24%
4,523,924
ALLO icon
2
Allogene Therapeutics
ALLO
$604M
$2.03M 12.76%
1,798,163
KRON
3
DELISTED
Kronos Bio
KRON
-2,765,314
Closed -$2.28M

Similar funds

Vida Ventures Advisors's Q2 2025 Portfolio in Review

As of Q2 2025, Vida Ventures Advisors held 3 positions worth $15.9M, up 17% from $13.6M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Vida Ventures Advisors withdrew a net $2.28M in Q2 2025, closing 1 position. Its most notable exit was Kronos Bio, an estimated $2.28M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Vida Ventures Advisors fully exited Kronos Bio in Q2 2025, selling an estimated $2.28M.
  • Vida Ventures Advisors's ten largest holdings make up 100% of its $15.9M portfolio in Q2 2025.
  • Vida Ventures Advisors opened 0 new positions and closed 1 in Q2 2025.
  • Vida Ventures Advisors's portfolio value rose 17% quarter-over-quarter to $15.9M.

Based on Vida Ventures Advisors's 13F filing for Q2 2025, filed 10 Jul 2025.